Abstract:Ferroptosis, a mode of cell death that was recently identified in 2012, is driven by iron-dependent lipid peroxidation and distinct from other mechanisms of cell death such as autophagy and apoptosis. Ferroptosis has the unique features of disruptions in iron equilibrium, iron-induced lipid peroxidation, and the accumulation of glutamate-induced cellular toxicity. The regulation of ferroptosis mainly involves the iron, lipid, and amino acid metabolic pathways, which are controlled by system Xc − , voltage-dependent anion channels, p53 and other pathways. Neurodegenerative diseases involve gradual neuronal loss predominantly within the central nervous system and are categorized into both sporadic and rare hereditary disorders. These diseases result in the progressive decline of specific neuron populations and their interconnections. Recent investigations have revealed a strong correlation between the manifestation and progression of neurodegenerative diseases and ferroptosis. The pharmacological modulation of ferroptosis, whether by induction or inhibition, exhibits promising prospects for therapeutic interventions for these diseases. This review aims to examine the literature on ferroptosis and its implications in various neurodegenerative diseases. We hope to offer novel insights into the potential therapies targeting ferroptosis in central nervous system neurodegenerative diseases. However, there are still limitations of this review. First, despite our efforts to maintain objectivity during our analysis, this review does not cover all the studies on ferroptosis and neurodegenerative diseases. Second, cell death in neurodegenerative diseases is not solely caused by ferroptosis. Future research should focus on the interplay of different cell death mechanisms to better elucidate the specific disease pathogenesis.

Research on Ferroptosis as a Therapeutic Target for the Treatment of Neurodegenerative Diseases

Insight into the Role of Ferroptosis in Non-neoplastic Neurological Diseases

Research progress on ferroptosis in the pathogenesis and treatment of neurodegenerative diseases

Mechanisms of Ferroptosis and Emerging Links to the Pathology of Neurodegenerative Diseases

The role of ferroptosis in neurodegenerative diseases

Ferroptosis: A potential therapeutic target for neurodegenerative diseases

Targeting Ferroptosis As a Potential Prevention and Treatmentstrategy for Human Diseases

Ferroptosis-Regulated Cell Death As a Therapeutic Strategy for Neurodegenerative Diseases: Current Status and Future Prospects

Insight into the potential role of ferroptosis in neurodegenerative diseases

Ferroptosis, a Potential Therapeutic Target in Alzheimer’s Disease

Ferroptosis: underlying mechanisms and involvement in neurodegenerative diseases

Understanding the Mechanism of Ferroptosis in Neurodegenerative Diseases

Targeting ferroptosis in neuroimmune and neurodegenerative disorders for the development of novel therapeutics

Ferroptosis: A new strategy for targeting Alzheimer's disease

Targeting ferroptosis opens new avenues for the development of novel therapeutics

Targeting Ferroptosis for Cancer Therapy: Exploring Novel Strategies from Its Mechanisms and Role in Cancers

Ferroptosis and its potential as a therapeutic target

The Role of Ferroptosis in Amyotrophic Lateral Sclerosis Treatment

Emerging Mechanisms and Targeted Therapy of Ferroptosis in Neurological Diseases and Neuro-oncology

Pharmacological Inhibition of Ferroptosis as a Therapeutic Target for Neurodegenerative Diseases and Strokes

A critical appraisal of ferroptosis in Alzheimer's and Parkinson's disease: new insights into emerging mechanisms and therapeutic targets